Latest Observability News

Memphasys has inked a five-year supply agreement with Italy’s Centro Fertilita Assistita, marking its first major European contract and setting the stage for broader adoption of its Felix™ sperm isolation system.

Immutep Limited reports encouraging Phase I results for IMP761, a novel LAG-3 agonist antibody targeting autoimmune diseases, demonstrating dose-dependent immunosuppression and a strong safety profile. Further trial updates are expected in early 2026.

Triton Minerals reports encouraging geological signs from its maiden drilling at the Aucu Gold-Copper Project despite operational hurdles, while legal delays stall the completion of its 70% graphite asset sale.

Burgundy Diamond Mines' subsidiary Arctic Canadian Diamond Company has secured a C$115 million senior secured loan from Canada's LETL facility to support operations amid US tariffs impacting diamond markets. The funding enables continued development and operational restructuring at the Ekati mine.

Artemis Resources confirms a significant gold-bearing shear zone at Titan East near its Carlow deposit, highlighted by a wide 19m intersection at 1.6g/t Au and a previous high-grade 5m intercept at 13.1g/t Au. Diamond drilling has commenced to better define this emerging gold system.

Great Northern Minerals has revealed a significant 1-kilometre quartz-stibnite vein with assays up to 7.1% antimony at its Catalyst Ridge Project, alongside plans to expand its footprint in California. The discovery hints at promising gold potential beneath the surface, echoing nearby major deposits.

Mayfield Childcare reports steady occupancy growth and improved earnings in late 2025, setting a stronger foundation for FY26 amid sector challenges and an impending takeover offer from Embark Education.

Boss Energy has withdrawn its 2021 Enhanced Feasibility Study for the Honeymoon uranium project due to significant deviations in resource assumptions, launching a new study focused on a wide-spaced wellfield design that could lower costs and improve recoverability.

BlinkLab Limited has appointed its Co-Founder and CEO, Dr Henk-Jan Boele, as Managing Director to steer the company through its pivotal FDA 510(k) trial for its autism diagnostic technology. The move coincides with key board changes and signals a strategic shift as BlinkLab prepares for early commercialisation.

Bio-Gene Technology reports promising progress on its US Department of Defense-funded insecticide projects, with early mosquito mortality evidence from its Flavocide wearable device and pending launch of its Qcide indoor spray program.

American Uranium Limited has successfully expanded uranium mineralisation trends by 3,000 metres at its Lo Herma ISR Project in Wyoming, delivering its strongest drill intercept to date and setting the stage for a 2026 resource update and scoping study.

Lake Resources has secured a crucial environmental management plan approval for its Kachi Lithium Project, marking a significant step toward final environmental impact assessment clearance and sustainable lithium production.